Bilthoven Biologicals Appoints New CEO: Jurgen Kwik 

BILTHOVEN, NETHERLANDS, MARCH 2024 - Bilthoven Biologicals (BBio) is pleased to announce the appointment of Mr. Jurgen Kwik as its new Chief Executive Officer (CEO). Mr. Kwik brings extensive experience in the Life Sciences sector. His tenure includes leadership positions such as the leader of the Global COVID-19 Vaccine Program Office and, more recently, Global Head Portfolio Strategy & Site Operations; Infectious Diseases & Vaccines R&D at Janssen.

Employee out of isolation, no spread of polio virus. Investigation ongoing.

This message is an update after the polio virus infection of an employee at Bilthoven Biologicals. After an employee of Bilthoven Biologicals became infected with the polio virus, he was placed in isolation. On January 11, 2023, the employee was able to get out of isolation again. The employee no longer carries the virus and can therefore no longer infect others. The virus was also not found in the contacts of the employee that was examined.
Laad meer